Professor Seán Kennelly from the Tallaght Institute of Memory and Cognition believes this study is a major step forward in ...

Researchers at the University of Pittsburgh have devised a biomarker test that can spot small amounts of clumping tau protein ...

Up to half of all people living with Alzheimer's Disease in Ireland remain undiagnosed. Now, a new blood test may have the potential to transform patient care, allowing for better diagnosis, earlier ...

Blood tests and the adoption of AI in cognitive decline screenings have opened the door to new avenues for testing cognitive ...

Up to half of all people living with Alzheimer's Disease in Ireland remain undiagnosed. Now, a new blood test may have the ...

Scientists have identified a biomarker for Alzheimer's that may help doctors spot the early signs of protein buildup in the ...

New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study estimates. But experts urge caution.

Research supporting the amyloid hypothesis—the idea that Alzheimer's is caused by a buildup of amyloid plaques in the ...

The biomarker test is a spinal tap test (also called a lumbar puncture) that uses a needle to remove cerebrospinal fluid (i.e ...

including young-onset dementia, usually starts with the GP (see Assessment process and tests). However, there is a wider range of possible causes of dementia in younger people, and so a more ...

Frontotemporal dementia (FTD) can be hard to diagnose, because it is an uncommon type of dementia and does not cause memory problems at first. However, there are some ways to diagnose FTD including ...

A breakthrough in the fight against Alzheimer's was made by researchers at the University of Pittsburgh, where a test was ...